Vitamin D in der Schmerztherapie

Zusammenfassung

Eine unzureichende diätetische Verfügbarkeit an neuroprotektiven Nährstoffen spielt bei der Pathogenese von Schmerzen eine wichtige Rolle. Deshalb sollte bei der Schmerzdiagnostik immer auch an die Versorgung mit Vitaminen und neuroprotektiven Nährstoffen gedacht werden. Neuroprotektive Substanzen wie Vitamin D können die pharmakologische Schmerztherapie sinnvoll unterstützen. Bei muskuloskelettalen Schmerzen unterschiedlicher Genese sollte ein Vitamin-D-Mangel (25(OH)D: < 20 ng/ml) unter ärztlicher Kontrolle ausgeglichen werden (Zielwert-25(OH)D: 40–60 ng/ml). Die Lebensqualität und Schmerzbelastung kann durch Vitamin D signifikant verbessert werden.

Abstract

An insufficient dietary availability of neuroprotective nutrients plays an important role in the pathogenesis of pain. Therefore, pain diagnostics should always take into consideration the supply with vitamins and neuroprotective nutrients too. Neuroprotective substances like vitamin D can provide a useful support for pharmacological pain therapy. In the case of musculoskeletal pain of differing etiology, a deficiency of vitamin D (25(OH)D: < 20ng/ml) should be balanced under medical supervision (target value-25(OH)D: 40–60ng/ml). The quality of life and the burden of pain can be significantly improved with the help of vitamin D.

Schlüsselwörter

Vitamin D - Schmerztherapie - neuropathische Schmerzen - nozizeptive Schmerzen

Key words

Vitamin D - pain therapy - neuropathic pain - nociceptive pain

• Literatur

• 1 Ames BN. Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triage. Proc Natl Acad Sci USA 2006; 103 (47) 17589-17594
• 2 Baggerly CA, Cuomo RE, French CB. et al. Sunlight and Vitamin D: Necessary for Public Health. J Am Coll Nutr 2015; 34 (04) 359-65
• 3 Binder A, Baron R. The pharmacological therapy of chronic neuropathic pain. Dtsch Arztebl Int 2016; 113: 616-626
• 4 Bittenbring JT, Neumann F, Altmann B. et al. Vitamin D deficiency impairs rituximab-mediated cellular cytotoxicity and outcome of patients with diffuse large B-cell lymphoma treated with but not without rituximab. J Clin Oncol 2014; 32 (29) 3242-3248
• 5 Churilla TM, Brereton HD, Klem M. et al. Vitamin D deficiency is widespread in cancer patients and correlates with advanced stage disease: a community oncology experience. Nutr Cancer 2012; 64 (04) 521-525
• 6 Deutsche Schmerzliga e. V.. Chronischer Schmerz: Daten, Fakten, Hintergründe. Presseinformation. 2013
• 7 Gendelman O, Itzhaki D, Makarov S. et al. A randomized double-blind placebo-controlled study adding high dose vitamin D to analgesic regimens in patients with musculoskeletal pain. Lupus 2015; 24 (04/05) 483-489
• 8 Glueck CJ, Budhani SB, Masineni SS. et al. Vitamin D deficiency, myositis-myalgia, and reversible statin intolerance. Curr Med Res Opin 2011; 27 (09) 1683-1690
• 9 Le Goaziou MF, Kellou N, Flori M. et al. Vitamin D supplementation for diffuse musculoskeletal pain: results of a before-and-after study. Eur J Gen Pract 2014; 20 (01) 3-9
• 10 Gröber U. Arzneimittel und Mikronährstoffe. 4. Aufl.. Stuttgart: Wissenschaftliche Verlagsgesellschaft; 2018
• 11 Gröber U. Gesund mit Vitamin D. München: Südwest; 2017
• 12 Gröber U, Holzhauer P, Kisters K. et al. Micronutrients in Oncological Intervention. Nutrients 2016; 8 (03) pii: E163 doi: 10.3390/nu8030163
• 13 Gröber U, Holick MF. Vitamin D: Die Heilkraft des Sonnenvitamins. 3. Aufl.. Stuttgart: Wissenschaftliche Verlagsgesellschaft; 2015
• 14 Gröber U, Reichrath J, Holick MF. Vitamin D: Update 2013: From rickets prophylaxis to general preventive healthcare. Dermatoendocrinol 2013; 5 (03) 331-347
• 15 Helde-Frankling M, Bergqvist J, Klasson C. et al. Vitamin D supplementation to palliative cancer patients: protocol of a double-blind, randomised controlled trial ‘Palliative-D’. BMJ Support Palliat Care 2017; 7 (04) 458-463
• 16 Hewison M. Vitamin D and immune function: an overview. Proc Nutr Soc 2012; 71 (01) 50-61
• 17 Hoel DG, Berwick M, de Gruijl FR. et al. The risks and benefits of sun exposure 2016. Dermatoendocrinol 2016; 8 (01) e1248325
• 18 Hohaus S, Tisi MC, Bellesi S. et al. Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy. Cancer Med 2018; 7 (01) 270-281
• 19 Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357 (03) 266-281
• 20 Jesus CA, Feder D, Peres MF. The role of vitamin D in pathophysiology and treatment of fibromyalgia. Curr Pain Headache Rep 2013; 17 (08) 355 doi: 10.1007/s11916–013–0355–6
• 21 Jetty V, Glueck CJ, Wang P. et al. Safety of 50,000–100,000 Units of Vitamin D3/Week in Vitamin D-Deficient, Hypercholesterolemic Patients with Reversible Statin Intolerance. N Am J Med Sci 2016; 8 (03) 156-162
• 22 Khayznikov M, Hemachrandra K, Pandit R. et al. Statin Intolerance Because of Myalgia, Myositis, Myopathy, or Myonecrosis Can in Most Cases be Safely Resolved by Vitamin D Supplementation. N Am J Med Sci 2015; 7 (03) 86-93
• 23 Manoy P, Yuktanandana P, Tanavalee A. et al. Vitamin D Supplementation Improves Quality of Life and Physical Performance in Osteoarthritis Patients. Nutrients 2017; 9 (08) pii: E799 doi: 10.3390/nu9080799
• 24 Mitsikostas DD, Tsaklakidou D, Athanasiadis N. et al. The prevalence of headache in Greece: correlations to latitude and climatological factors. Headache 1996; 36 (03) 168-173
• 25 Munger KL, Levin LI, Hollis BW. et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 20.12.2006; 296 (23) 2832-8
• 26 Oh RC, Johnson JD. Chest pain and costochondritis associated with vitamin d deficiency: a report of two cases. Case Rep Med 2012; 2012: 375730 doi: 10.1155/2012/375730
• 27 de Oliveira DL, Hirotsu C, Tufik S. et al. The interfaces between vitamin D, sleep and pain. J Endocrinol 2017; 234 (01) R23-R36
• 28 Ooi JH, Chen J, Cantorna MT. Vitamin D regulation of immune function in the gut: why do T cells have vitamin D receptors?. Mol Aspects Med 2012; 33 (01) 77-82
• 29 Radujkovic A, Kordelas L, Krzykalla J. et al. Pretransplant Vitamin D Deficiency Is Associated with Higher Relapse Rates in Patients Allografted for Myeloid Malignancies. J Clin Oncol 2017; 35 (27) 3143-3152
• 30 Saps M, Blank C, Khan S. et al. Seasonal variation in the presentation of abdominal pain. J Pediatr Gastroenterol Nutr 2008; 46 (03) 279-284
• 31 Stroes ES, Thompson PD, Corsini A. et al. Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management. Eur Heart J 2015; 36 (17) 1012-1022
• 32 Waikakul S. Serum 25-hydroxy-calciferol level and failed back surgery syndrome. J Orthop Surg (Hong Kong) 2012; 20 (01) 18-22
• 33 Wepner F, Scheuer R, Schuetz-Wieser B. et al. Effects of vitamin D on patients with fibromyalgia syndrome: a randomized placebo-controlled trial. Pain 2014; 155 (02) 261-268
• 34 Yilmaz R, Salli A, Cingoz HT. et al. Efficacy of vitamin D replacement therapy on patients with chronic nonspecific widespread musculoskeletal pain with vitamin D deficiency. Int J Rheum Dis 2016; 19 (12) 1255-1262